A Defense of Limited Regulation of Human Genetic Therapies
There is a role for regulatory oversight over new genetic technologies. Research must ensure the rights of human subjects, and all medical products and techniques should be ensured to be safe and effective. In the United States, these forms of regulation are largely the purview of the National Insti...
Main Author: | |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Cambridge Univ. Press
2019
|
In: |
Cambridge quarterly of healthcare ethics
Year: 2019, Volume: 28, Issue: 1, Pages: 112-120 |
Further subjects: | B
Ethics
B germline B Gene Therapy B Bioethics B heritable |
Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |